{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:01:29Z","timestamp":1790233289408,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100003053","name":"Alberta Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Qual Life Outcomes"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12955-017-0828-0","type":"journal-article","created":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T08:43:39Z","timestamp":1513845819000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Discriminative ability of quality of life measures in multiple sclerosis"],"prefix":"10.1186","volume":"15","author":[{"given":"Kirsten M.","family":"Fiest","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Greenfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luanne M.","family":"Metz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott B.","family":"Patten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Jett\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth Ann","family":"Marrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,21]]},"reference":[{"issue":"3","key":"828_CR1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/1352458514564491","volume":"21","author":"RA Marrie","year":"2015","unstructured":"Marrie RA, Cohen J, Stuve O, Trojano M, Sorensen PS, Reingold S, et al. A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: overview. Mult Scler. 2015;21(3):263\u201381.","journal-title":"Mult Scler"},{"issue":"8","key":"828_CR2","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1177\/1352458508092263","volume":"14","author":"RA Marrie","year":"2008","unstructured":"Marrie RA, Horwitz R, Cutter G, Tyry T, Campagnolo D, Vollmer T. Comorbidity, socioeconomic status and multiple sclerosis. Mult Scler. 2008;14(8):1091\u20138.","journal-title":"Mult Scler"},{"issue":"2","key":"828_CR3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1212\/01.wnl.0000333252.78173.5f","volume":"72","author":"RA Marrie","year":"2009","unstructured":"Marrie RA, Horwitz R, Cutter G, Tyry T, Campagnolo D, Vollmer T. Comorbidity delays diagnosis and increases disability at diagnosis in MS. Neurology. 2009;72(2):117\u201324.","journal-title":"Neurology"},{"key":"828_CR4","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/1742-2094-8-127","volume":"8","author":"B Weinstock-Guttman","year":"2011","unstructured":"Weinstock-Guttman B, Zivadinov R, Mahfooz N, Carl E, Drake A, Schneider J, et al. Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis. J Neuroinflammation. 2011;8:127.","journal-title":"J Neuroinflammation"},{"issue":"8","key":"828_CR5","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1177\/1352458507078393","volume":"13","author":"KV Turpin","year":"2007","unstructured":"Turpin KV, Carroll LJ, Cassidy JD, Hader WJ. Deterioration in the health-related quality of life of persons with multiple sclerosis: the possible warning signs. Mult Scler. 2007;13(8):1038\u201345.","journal-title":"Mult Scler"},{"issue":"5","key":"828_CR6","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1017\/S0317167100008003","volume":"36","author":"S Warren","year":"2009","unstructured":"Warren S, Turpin KV, Warren KG. Health-related quality of life in MS: issues and interventions. Can J Neurol Sci. 2009;36(5):540\u20131.","journal-title":"Can J Neurol Sci"},{"key":"828_CR7","doi-asserted-by":"crossref","unstructured":"Berrigan L, Fisk J, Patten S, Tremlett H, Wolfson C, Warren S, et al. Health-related quality of life in multiple sclerosis: direct and indirect effects of comorbidity. Neurology. 2016;86(15):1417\u201324.","DOI":"10.1212\/WNL.0000000000002564"},{"issue":"1\u20132","key":"828_CR8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jns.2004.12.009","volume":"231","author":"RH Benedict","year":"2005","unstructured":"Benedict RH, Wahlig E, Bakshi R, Fishman I, Munschauer F, Zivadinov R, et al. Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change. J Neurol Sci. 2005;231(1\u20132):29\u201334.","journal-title":"J Neurol Sci"},{"issue":"5","key":"828_CR9","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1212\/WNL.53.5.1098","volume":"53","author":"MW Nortvedt","year":"1999","unstructured":"Nortvedt MW, Riise T, Myhr KM, Nyland HI. Quality of life in multiple sclerosis: measuring the disease effects more broadly. Neurology. 1999;53(5):1098\u2013103.","journal-title":"Neurology"},{"issue":"8","key":"828_CR10","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1136\/jnnp.2006.090365","volume":"77","author":"G Kobelt","year":"2006","unstructured":"Kobelt G, Berg J, Lindgren P, Fredrikson S, Jonsson B. Costs and quality of life of patients with multiple sclerosis in Europe. J Neurol Neurosurg Psychiatry. 2006;77(8):918\u201326.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"828_CR11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1177\/1352458507080464","volume":"14","author":"RW Motl","year":"2008","unstructured":"Motl RW, Gosney JL. Effect of exercise training on quality of life in multiple sclerosis: a meta-analysis. Mult Scler. 2008;14(1):129\u201335.","journal-title":"Mult Scler"},{"issue":"12","key":"828_CR12","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1007\/s12325-009-0082-x","volume":"26","author":"HL Zwibel","year":"2009","unstructured":"Zwibel HL. Contribution of impaired mobility and general symptoms to the burden of multiple sclerosis. Adv Ther. 2009;26(12):1043\u201357.","journal-title":"Adv Ther"},{"issue":"2","key":"828_CR13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1191\/135245800678827545","volume":"6","author":"DT Grima","year":"2000","unstructured":"Grima DT, Torrance GW, Francis G, Rice G, Rosner AJ, Lafortune L. Cost and health related quality of life consequences of multiple sclerosis. Mult Scler. 2000;6(2):91\u20138.","journal-title":"Mult Scler"},{"issue":"1","key":"828_CR14","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1136\/jnnp.2003.017897","volume":"76","author":"JD Fisk","year":"2005","unstructured":"Fisk JD, Brown MG, Sketris IS, Metz LM, Murray TJ, Stadnyk KJ. A comparison of health utility measures for the evaluation of multiple sclerosis treatments. J Neurol Neurosurg Psychiatry. 2005;76(1):58\u201363.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"828_CR15","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1212\/WNL.45.2.251","volume":"45","author":"MJ Hohol","year":"1995","unstructured":"Hohol MJ, Orav EJ, Weiner HL. Disease steps in multiple sclerosis: a simple approach to evaluate disease progression. Neurology. 1995;45(2):251\u20135.","journal-title":"Neurology"},{"key":"828_CR16","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1471-2377-13-37","volume":"13","author":"YC Learmonth","year":"2013","unstructured":"Learmonth YC, Motl RW, Sandroff BM, Pula JH, Cadavid D. Validation of patient determined disease steps (PDDS) scale scores in persons with multiple sclerosis. BMC Neurol. 2013;13:37.","journal-title":"BMC Neurol"},{"issue":"1","key":"828_CR17","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0895-4356(02)00537-1","volume":"56","author":"S Wiebe","year":"2003","unstructured":"Wiebe S, Guyatt G, Weaver B, Matijevic S, Sidwell C. Comparative responsiveness of generic and specific quality-of-life instruments. J Clin Epidemiol. 2003;56(1):52\u201360.","journal-title":"J Clin Epidemiol"},{"key":"828_CR18","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1477-7525-1-54","volume":"1","author":"J Horsman","year":"2003","unstructured":"Horsman J, Furlong W, Feeny D, Torrance G. The health utilities index (HUI): concepts, measurement properties and applications. Health Qual Life Outcomes. 2003;1:54.","journal-title":"Health Qual Life Outcomes"},{"issue":"3","key":"828_CR19","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF02260859","volume":"4","author":"BG Vickrey","year":"1995","unstructured":"Vickrey BG, Hays RD, Harooni R, Myers LW, Ellison GW. A health-related quality of life measure for multiple sclerosis. Qual Life Res. 1995;4(3):187\u2013206.","journal-title":"Qual Life Res"},{"issue":"6","key":"828_CR20","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","volume":"30","author":"JE Ware Jr","year":"1992","unstructured":"Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473\u201383.","journal-title":"Med Care"},{"issue":"2","key":"828_CR21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0167-6296(01)00130-8","volume":"21","author":"J Brazier","year":"2002","unstructured":"Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002;21(2):271\u201392.","journal-title":"J Health Econ"},{"issue":"2","key":"828_CR22","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2340\/16501977-0024","volume":"39","author":"AJ Dallmeijer","year":"2007","unstructured":"Dallmeijer AJ, de Groot V, Roorda LD, Schepers VP, Lindeman E, van den Berg LH, et al. Cross-diagnostic validity of the SF-36 physical functioning scale in patients with stroke, multiple sclerosis and amyotrophic lateral sclerosis: a study using Rasch analysis. J Rehabil Med. 2007;39(2):163\u20139.","journal-title":"J Rehabil Med"},{"issue":"4","key":"828_CR23","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1191\/1352458503ms929oa","volume":"9","author":"A Riazi","year":"2003","unstructured":"Riazi A, Hobart JC, Lamping DL, Fitzpatrick R, Thompson AJ. Evidence-based measurement in multiple sclerosis: the psychometric properties of the physical and psychological dimensions of three quality of life rating scales. Mult Scler. 2003;9(4):411\u20139.","journal-title":"Mult Scler"},{"issue":"8","key":"828_CR24","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s40273-014-0167-5","volume":"32","author":"A Kuspinar","year":"2014","unstructured":"Kuspinar A, Mayo NE. A review of the psychometric properties of generic utility measures in multiple sclerosis. PharmacoEconomics. 2014;32(8):759\u201373.","journal-title":"PharmacoEconomics"},{"issue":"1","key":"828_CR25","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1212\/WNL.57.1.68","volume":"57","author":"JA Freeman","year":"2001","unstructured":"Freeman JA, Hobart JC, Thompson AJ. Does adding MS-specific items to a generic measure (the SF-36) improve measurement? Neurology. 2001;57(1):68\u201374.","journal-title":"Neurology"},{"issue":"1","key":"828_CR26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1017\/cjn.2014.128","volume":"42","author":"F Moore","year":"2015","unstructured":"Moore F, Vickrey B, Fortin K, Lee L. Two multiple sclerosis quality-of-life measures: comparison in a National Sample. Can J Neurol Sci. 2015;42(1):55\u201363.","journal-title":"Can J Neurol Sci"},{"issue":"2","key":"828_CR27","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000311013","volume":"35","author":"M Horton","year":"2010","unstructured":"Horton M, Rudick RA, Hara-Cleaver C, Marrie RA. Validation of a self-report comorbidity questionnaire for multiple sclerosis. Neuroepidemiology. 2010;35(2):83\u201390.","journal-title":"Neuroepidemiology"},{"key":"828_CR28","unstructured":"Swinscow TDV, 11. Correlation and regression, in Statistics at Square One. London: BMJ Publishing Group. 1997."},{"issue":"7","key":"828_CR29","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/MLR.0b013e31824d7471","volume":"50","author":"N Luo","year":"2012","unstructured":"Luo N, Wang P, AZ F, Johnson JA, Coons SJ. Prefderence-based SF-6D scores derived from the SF-36 and SF-12 have different discriminative power in a population health survey. Med Care. 2012;50(7):627\u201332.","journal-title":"Med Care"},{"issue":"5","key":"828_CR30","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.msard.2015.07.014","volume":"4","author":"KM Fiest","year":"2015","unstructured":"Fiest KM, Fisk JD, Patten SB, Tremlett H, Wolfson C, Warren S, et al. Comorbidity is associated with pain-related activity limitations in multiple sclerosis. Mult Scler Relat Disord. 2015;4(5):470\u20136.","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"828_CR31","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7224\/1537-2073.2012-046","volume":"16","author":"M Buhse","year":"2014","unstructured":"Buhse M, Banker WM, Clement LM. Factors associated with health-related quality of life among older people with multiple sclerosis. Int J MS Care. 2014;16(1):10\u20139.","journal-title":"Int J MS Care"},{"issue":"2","key":"828_CR32","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S1474-4422(14)70264-9","volume":"14","author":"D Ontaneda","year":"2015","unstructured":"Ontaneda D, Fox RJ, Chataway J. Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives. Lancet Neurol. 2015;14(2):208\u201323.","journal-title":"Lancet Neurol"},{"issue":"3","key":"828_CR33","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1017\/cjn.2015.350","volume":"43","author":"LM Metz","year":"2016","unstructured":"Metz LM, Greenfield J, Marrie R, Jette N, Blevens G, Svenson L, et al. Medical tourism for CCSVI procedures in people with MS: an observational study. Can J Neurol Sci. 2016;43(3):360\u20137.","journal-title":"Can J Neurol Sci"}],"container-title":["Health and Quality of Life Outcomes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-017-0828-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T08:44:01Z","timestamp":1513845841000},"score":1,"resource":{"primary":{"URL":"https:\/\/hqlo.biomedcentral.com\/articles\/10.1186\/s12955-017-0828-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["828"],"URL":"https:\/\/doi.org\/10.1186\/s12955-017-0828-0","relation":{},"ISSN":["1477-7525"],"issn-type":[{"value":"1477-7525","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]},"article-number":"246"}}